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SAH, tumor or they had intraventricular
hemorrhage.8
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In addition to these variables, a biomarker
predictive of sepsis can be helpful in
differentiating infectious from central
fever and can also aid in antibiotic
stewardship.
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ABSTRACT
Fever is frequent in patients with neurologic injury. Differentiating infectious fever
from central fever can be challenging. It is important to diagnose the cause of fever
in the neurological intensive care unit because of the detrimental effects of fever on
brain injured patients. This is a comprehensive review of the role of the two commonly
available biomarkers, C-reactive protein and procalcitonin in differentiating the central
fever from infectious fever.
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INTRODUCTION AND BACKGROUND
Fever is frequently seen in the neurologic intensive care unit (NICU). Incidence rates
of up to 70% have been reported in various studies.1-5 Fever can help host defenses
by local activation of the coagulation cascade, cytokine-mediated T-cell activation,
as well as neutrophil and macrophage recruitment to injured tissues. In brain injured
patients, after the initial insult, secondary neuronal injury is speculated to be caused
by several processes including mitochondrial dysfunction, inflammatory response,
free radical generation, and excitatory neurotransmitter release. Fever has been shown
to exacerbate secondary neuronal injury and physiologic dysfunction after traumatic
brain injury (TBI), subarachnoid hemorrhage (SAH), and major neurosurgery.6

CAUSES OF FEVER IN NEUROLOGICALLY INJURED PATIENTS
Infections are the most common cause of fever in the NICU population, accounting
for at least half of the febrile episodes. 2,4-7 A significant percentage of patients in the
NICU have central fevers. Central fever results from loss of physiological regulation of
body temperature by the hypothalamus.7 The diagnosis of central fever is challenging
as there is no clear definition or diagnostic criteria. In addition, the prevalence of
systemic inflammatory response syndrome (SIRS) and leukocytosis may be similar in
patients with both central and infectious fevers.8 When there is clinical suspicion of
infection, it is common practice to initiate broad spectrum antibiotics after obtaining
appropriate culture specimens in ICU patients. This practice results in another challenge for neurointensivists as many patients with brain injury have central fever and
antibiotics may be continued unnecessarily in these patients. This may result in the
emergence of antibiotic resistant organisms, increase side effects of antibiotics as well
as healthcare costs. A better understanding of predictors of central fever is important
as it will help in antibiotic stewardship and may also allow for earlier discontinuation
of antibiotics in patients with central fever. 2 Rabinstein et al identified a number of
variables that are predictive of central fever in the neurocritical care population. Their
study showed that in patients with onset of fever within 72 hours of admission, patients
with persistent fevers, negative cultures and lack of infiltrates on chest X-ray were
more likely to have central fever. This was especially true if their primary diagnosis was
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Overview of Biomarkers
Ideally, in order to guide antibiotic use,
clinicians need a valid, reliable and
readily available test that would correlate well with their clinical suspicion and
also help them in differentiating between
central and infectious fever. A number of
biomarkers have been studied in patients
with sepsis, some of which have also
been evaluated in brain injured patients.
One of the more promising ones is
procalcitonin (PCT). Other biomarkers
include C reactive protein (CRP) and
Interleukin-6 (IL-6). These biomarkers
and their validity, efficacy and availability
in intensive care unit are discussed under.

Procalcitonin
Procalcitonin (PCT) is a glycopeptide
consisting of 116 amino acids produced
under normal conditions in the C cells of
the thyroid gland as the precursor molecule of calcitonin. Several studies have
demonstrated that PCT levels are raised
in severe invasive bacterial infections and
decrease rapidly after appropriate antibiotic therapy.9-14 In contrast, PCT levels
are normal or only slightly increased in
localized bacterial infections, viral infections, and inflammatory reactions of
noninfectious origin.9,15-17 There is recent
evidence suggesting that PCT can distinguish sepsis from non-infectious SIRS in
general critical care patients, allowing
clinicians to make better diagnostic and
therapeutic decisions.18-21

Procalcitonin vs. Other Biomarkers
A number of studies have evaluated the
role of PCT in comparison with CRP
and IL-6 as a diagnostic and prognostic
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biomarker. In a prospective cohort study
Ville Pettilä et al evaluated the predictive
value of PCT and IL-6 in patients with
suspected sepsis. PCT and IL-6 values on
day 2 of suspected sepsis were independently predictive of hospital mortality. 22
Simon et al conducted a systemic
review and meta-analysis. They studied
the relation between serum PCT and
CRP levels as a marker of inflammation.
PCT had higher accuracy than CRP for
discriminating bacterial infections from
non-infectious causes of inflammation.
In addition PCT was also significantly
better than CRP in differentiating bacterial from viral infections. 23
Choi et al conducted a prospective study
to evaluate the predictive performance
of serum PCT as a differentiating marker
between postoperative bacterial meningitis (PBM) and postoperative aseptic
meningitis (PAM). For the diagnosis of
PBM, PCT level ≥ 0.15 ng/mL had a specificity of 80.0% and sensitivity of 50%.
The combined criteria of a CRP level
≥2.5 mg/dL, WBC count ≥ 9,500/mm3,
and PCT level ≥ 0.15 ng/mL had the
highest specificity of 92.6% and higher
sensitivity of 85.7%. They concluded that
PCT alone has a limited performance for
the diagnosis of PBM, but has improved
diagnostic value when used as an adjunct
test with other inflammatory markers. 24

Procalcitonin as a biomarker for
diagnosis of sepsis in brain injured
patients
Fever is common in brain injured
patients. As stated earlier, a significant
proportion of these patients have
central fever and differentiating central
from infectious fever is challenging. In a
prospective observational study, Festic et
al showed that PCT may be a useful tool
when managing SIRS in a patient with
aneurysmal subarachnoid hemorrhage
(aSAH). They found that in these patients,
serum PCT values have high specificity,
high negative predictive value and good
overall predictive utility for infections,
particularly for major infections. Patients
with infection were > 25 times more likely
to have an elevated PCT values compared
to those with no infection. For patients
with a major infection, the odds ratio was
even higher (>33). 25

Early diagnosis of bacterial or viral
meningitis is important so that antibiotic
treatment can be started without delay.
For immediate diagnosis of bacterial
meningitis, the sensitivity of direct cerebrospinal fluid (CSF) examination or the
detection of bacterial antigens in CSF is
low. 26-29
Viallon et al conducted a prospective
study to determine the ability of inflammatory biomarkers commonly used
for the diagnosis of acute meningitis
to differentiate between bacterial and
viral meningitis, in adult patients with a
negative CSF examination. Out of 254
patients with meningitis with a negative
direct CSF examination, 35 had bacterial
meningitis and 181 had viral meningitis.
Serum PCT was a highly discriminative
biomarker and had a sensitivity of 95%, a
specificity of 100%, a negative predictive
value of 100%, and a positive predictive
value of 97% at a diagnostic cut-off level
of 0.28 ng/ml . 30
In another prospective study, Berger et
al measured daily PCT levels in patients
requiring temporary external ventricular
drains (EVD). They showed that PCT
levels were significantly higher (4.7 vs 0.2
ng/ml) in patients with proven cerebral
ventriculitits. CSF cell count could not
differentiate bacterial infections from
abacterial reactions. 31
Martinez et al measured serum PCT in
15 consecutive patients with ventriculitis

in which an EVD had been inserted and
compared the data with ten patients
who had bacterial meningitis. Four out
of fifteen patients had microbiologically proven bacterial ventriculitis with
positive bacterial cultures. PCT value of
1.0 ng/ml showed a specificity of 77%
and sensitivity of 68% in patients with
ventriculitis with positive CSF bacterial
cultures. 32
In a prospective case series Schwarz et al
compared serum PCT levels in patients
with bacterial meningitis to those with
abacterial meningitis. At admission, PCT
levels were significantly higher in patients
with bacterial meningitis as compared
with those with abacterial meningitis (p
< .001). The specificity of PCT was 100%
for bacterial infections, but there were
false-negative findings in five patients
with bacterial meningitis (a sensitivity of
69%). Persistently elevated or increasing
PCT levels after 2 days were associated
with an unfavorable clinical course.33
In a case series comparing 7 patients
with Neuro-Behcet disease to 3 patients
with bacterial meningitis, Suzuki et al
showed that serum PCT levels were
increased in patients with bacterial
meningitis, but not in those with NeuroBehcet disease. Therefore, serum PCT
may be a useful marker for discrimination between Neuro-Behcet disease and
septic meningitis, especially in cases of
the meningeal form of Neuro-Behcet
disease. 34

Figure 1. Studies describing the role of Procalcitonin as a differentiating marker.
Study

PCT Cut off

No. of
Patients

Specificity

Sensitivity

PPV

NPV

Festic et al.
(25)

0.2

40

97.7

37.5

85.7

80.8

Viallon et al.
(29)

0.28

254

100

95

97

100

Berger et al.
(31)

>1

34

100

100

100

100

Schwarz et al.
(33)

>0.5

30

100

69

100

74

Martinez et al.
(32)

1

15

77

68

NA

NA

PCT: Procalcitonin. PPV: Positive Predictive Value. NPV: Negative Predictive Value.
PCT Cut of value is ng/ml for all studies.
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Results of these studies show that PCT
can serve as a valuable tool in differentiating central fever from infectious fever,
as well as discriminating primary bacterial CNS infections from non-bacterial
CNS inflammatory processes.

C-Reactive Protein as a biomarker
in Neurologically Injured Patients:
CRP is a major acute-phase plasma
protein which is rapidly released in
response to infection or tissue injury. We
will discuss the role of CRP as a differentiating marker in CNS infections and
other CNS inflammatory conditions. In a
retrospective analysis of 35 patients with
brain abscess requiring surgical drainage,
Neidert et al found that preoperative
mean CRP levels were significantly higher
in the group requiring repeated surgical
drainage. They concluded that patients
with higher CRP level at baseline should
be monitored closely to determine the
need for repeat surgical drainage. 35
Cerebral vasospasm is a common and
potentially devastating complication of
aneurysmal subarachnoid hemorrhage
(aSAH). An inflammatory mechanism
is implicated in the development of
vasospasm. In a prospective study of 61
adult patients with aSAH, Hwang et al
measured Serum CRP levels on days 1, 3,
5, 7, 9, 11 and 13 after aneurysm rupture.
They found that Serum CRP levels peaked
on the 3rd postoperative day and there
were significant differences between
the vasospasm group and the nonvasospasm group on the days 1, 3 and 5.
They suggested that these patients may
require closer observation to monitor for
the development of vasospasm. 36
In a prospective study of 100 adult
patients with aneurysmal SAH, Romero
et al showed that higher serum CRP
levels are associated with worse clinical
outcome and the occurrence of delayed
ischemic neurological deficits. 37 In a
prospective study, Napoli et al evaluated
whether elevation of white blood cell
count (WBC), C-reactive protein (CRP),
and blood glucose (BG) concentration
at presentation were prognostic of poor
outcome in spontaneous Intracerebral
Hemorrhage (sICH) patients. Higher
WBC, CRP, and BG were associated with
increased mortality in univariate analysis.
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However, only CRP elevation remained
associated with mortality in the multivariate model, after adjusting for multiple
confounders. 38
The review of the studies related to
CRP show that it is raised universally
in all kinds of inflammatory responses,
whether infectious or noninfectious. It
may be useful in addition to PCT, but it
cannot be solely used to differentiate
between infectious and noninfectious
fever. As a result its utility for antibiotic
stewardship in NICU is limited.

CONCLUSIONS AND FUTURE
APPROACHES:
The development of fever in critically ill
patient needs immediate attention and
action to rule out infection. This situation
is more challenging in the NICU patient
population due to the high rate of noninfectious fever. On one hand there is high
morbidity and mortality associated with
sepsis, but on the other hand use of
broad spectrum antibiotics in patients
who do not have infection results in high
rates of antibiotic resistance, infections,
and adverse drug reactions. In order to
help diagnosis, a test is definitely needed
that can differentiate between infectious and noninfectious fever. If a test
helps us rule out infection and diagnose
central fever correctly, then in spite of
unnecessary use of antibiotics, we can
use novel techniques such as surface or
intravascular cooling measures like artic
sun to treat hyperthermia in brain injured
patients.
We conclude from the above review
of literature that PCT may be a more
sensitive and specific test that can help
us differentiate between infectious and
central fever. In addition it can also be
a useful test to differentiate between
primary bacterial CNS infections vs other
types of CNS infections or non-infectious
CNS inflammatory processes. However,
data is very limited in neurocritical and
neurosurgical patient populations.
More clinical studies and clinical trials
are needed that can validate the use of
PCT as a diagnostic test to differentiate
between infectious and noninfectious
fever. In addition, the diagnostic cut-off
levels of PCT also need to be validated.
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